Europe Continuous Glucose Monitoring Systems (CGMS) Market (2016-2022)
The Europe Continuous Glucose Monitoring Systems (CGMS) Market is expected to grow at a CAGR of 28.7% from 2016 to 2022. The CGMS is a relatively more efficient monitoring and treatment system for patients suffering from diabetes. However, lack of effective reimbursement system for devices and clinicians would be a major barrier to the adoption of the devices.
The component segment of the CGMS market includes transmitters and receivers, sensors and CGMS compatible insulin pumps. Sensors market was the major segment with largest market share, with revenue of $101.3 million in 2015 and is anticipated to register a CAGR of 30.0% during the forecast period.
The CGMS devices have witnessed continuous technological evolution CGMS with smartphone connectivity. Wearable CGMS is another promising product with tremendous potential within the wearable healthcare devices. Non-invasive CGMS such as Symphony CGM System, due to its user-friendliness, extensive applications and FDA approvals for the same, have gained prominence over the years.
The report highlights the adoption of Continuous Glucose Monitoring Systems in Europe. Based on the Component, the Europe Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The countries included in the report are Germany, UK, France, Russia, Spain, Italy and Rest of Europe region.
Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.
The component segment of the CGMS market includes transmitters and receivers, sensors and CGMS compatible insulin pumps. Sensors market was the major segment with largest market share, with revenue of $101.3 million in 2015 and is anticipated to register a CAGR of 30.0% during the forecast period.
The CGMS devices have witnessed continuous technological evolution CGMS with smartphone connectivity. Wearable CGMS is another promising product with tremendous potential within the wearable healthcare devices. Non-invasive CGMS such as Symphony CGM System, due to its user-friendliness, extensive applications and FDA approvals for the same, have gained prominence over the years.
The report highlights the adoption of Continuous Glucose Monitoring Systems in Europe. Based on the Component, the Europe Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The countries included in the report are Germany, UK, France, Russia, Spain, Italy and Rest of Europe region.
Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Continuous Glucose Monitoring Systems Market, by Component
1.4.2 Europe Continuous Glucose Monitoring Systems Market, by End User
1.4.3 Europe Continuous Glucose Monitoring Systems Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.2 Key Influencing Factors
2.2.1 Drivers
2.2.2 Restraints
2.2.3 Opportunities
2.3 Europe Continuous Glucose Monitoring Systems Market
2.3.1 Europe Continuous Glucose Monitoring Systems Market - By Component
2.3.2 Europe Continuous Glucose Monitoring Systems Market - By End User
CHAPTER 3. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT
3.1 Europe Continuous Glucose Monitoring Systems Sensors Market - By Country
3.2 Europe Continuous Glucose Monitoring Transmitters & Receivers Market - By Country
3.3 Europe Continuous Glucose Monitoring Systems Integrated Insulin pumps Market - By Country
CHAPTER 4. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER
4.1 Europe Diagnostic centers/clinics Continuous Glucose Monitoring Systems Market - By Country
4.2 Europe ICUs Continuous Glucose Monitoring Systems Market - By Country
4.3 Europe Home Healthcare Continuous Glucose Monitoring Systems Market - By Country
CHAPTER 5. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY
5.1 Germany Continuous Glucose Monitoring Systems Market
5.1.1 Germany Continuous Glucose Monitoring Systems Market - By Component
5.1.2 Germany Continuous Glucose Monitoring Systems Market - By End User
5.2 UK Continuous Glucose Monitoring Systems Market
5.2.1 UK Continuous Glucose Monitoring Systems Market - By Component
5.2.2 UK Continuous Glucose Monitoring Systems Market - By End User
5.3 France Continuous Glucose Monitoring Systems Market
5.3.1 France Continuous Glucose Monitoring Systems Market - By Component
5.3.2 France Continuous Glucose Monitoring Systems Market - By End User
5.4 Russia Continuous Glucose Monitoring Systems Market
5.4.1 Russia Continuous Glucose Monitoring Systems Market - By Component
5.4.2 Russia Continuous Glucose Monitoring Systems Market - By End User
5.5 Spain Continuous Glucose Monitoring Systems Market
5.5.1 Spain Continuous Glucose Monitoring Systems Market - By Component
5.5.2 Spain Continuous Glucose Monitoring Systems Market - By End User
5.6 Italy Continuous Glucose Monitoring Systems Market
5.6.1 Italy Continuous Glucose Monitoring Systems Market - By Component
5.6.2 Italy Continuous Glucose Monitoring Systems Market - By End User
5.7 Rest of Europe Continuous Glucose Monitoring Systems Market
5.7.1 Rest of Europe Continuous Glucose Monitoring Systems Market - By Component
5.7.2 Rest of Europe Continuous Glucose Monitoring Systems Market - By End User
CHAPTER 6. COMPANY PROFILE
6.1 Roche Diagnostics.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Analysis
6.2 Abbott Laboratories
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental Analysis
6.2.4 Research & Development Analysis
6.3 Dexcom, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Research & Development Analysis
6.4 Novo Nordisk.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Analysis
6.5 Ypsomed AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.6 GlySens Incorporated.
6.6.1 Company Overview
6.7 Medtronic Plc
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental Analysis
6.7.4 Research & Development Analysis
6.8 Johnson & Johnson.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Research & Development Analysis
6.8.4 Segmental Analysis
?
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Continuous Glucose Monitoring Systems Market, by Component
1.4.2 Europe Continuous Glucose Monitoring Systems Market, by End User
1.4.3 Europe Continuous Glucose Monitoring Systems Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.2 Key Influencing Factors
2.2.1 Drivers
2.2.2 Restraints
2.2.3 Opportunities
2.3 Europe Continuous Glucose Monitoring Systems Market
2.3.1 Europe Continuous Glucose Monitoring Systems Market - By Component
2.3.2 Europe Continuous Glucose Monitoring Systems Market - By End User
CHAPTER 3. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT
3.1 Europe Continuous Glucose Monitoring Systems Sensors Market - By Country
3.2 Europe Continuous Glucose Monitoring Transmitters & Receivers Market - By Country
3.3 Europe Continuous Glucose Monitoring Systems Integrated Insulin pumps Market - By Country
CHAPTER 4. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER
4.1 Europe Diagnostic centers/clinics Continuous Glucose Monitoring Systems Market - By Country
4.2 Europe ICUs Continuous Glucose Monitoring Systems Market - By Country
4.3 Europe Home Healthcare Continuous Glucose Monitoring Systems Market - By Country
CHAPTER 5. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY
5.1 Germany Continuous Glucose Monitoring Systems Market
5.1.1 Germany Continuous Glucose Monitoring Systems Market - By Component
5.1.2 Germany Continuous Glucose Monitoring Systems Market - By End User
5.2 UK Continuous Glucose Monitoring Systems Market
5.2.1 UK Continuous Glucose Monitoring Systems Market - By Component
5.2.2 UK Continuous Glucose Monitoring Systems Market - By End User
5.3 France Continuous Glucose Monitoring Systems Market
5.3.1 France Continuous Glucose Monitoring Systems Market - By Component
5.3.2 France Continuous Glucose Monitoring Systems Market - By End User
5.4 Russia Continuous Glucose Monitoring Systems Market
5.4.1 Russia Continuous Glucose Monitoring Systems Market - By Component
5.4.2 Russia Continuous Glucose Monitoring Systems Market - By End User
5.5 Spain Continuous Glucose Monitoring Systems Market
5.5.1 Spain Continuous Glucose Monitoring Systems Market - By Component
5.5.2 Spain Continuous Glucose Monitoring Systems Market - By End User
5.6 Italy Continuous Glucose Monitoring Systems Market
5.6.1 Italy Continuous Glucose Monitoring Systems Market - By Component
5.6.2 Italy Continuous Glucose Monitoring Systems Market - By End User
5.7 Rest of Europe Continuous Glucose Monitoring Systems Market
5.7.1 Rest of Europe Continuous Glucose Monitoring Systems Market - By Component
5.7.2 Rest of Europe Continuous Glucose Monitoring Systems Market - By End User
CHAPTER 6. COMPANY PROFILE
6.1 Roche Diagnostics.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Analysis
6.2 Abbott Laboratories
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental Analysis
6.2.4 Research & Development Analysis
6.3 Dexcom, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Research & Development Analysis
6.4 Novo Nordisk.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Analysis
6.5 Ypsomed AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.6 GlySens Incorporated.
6.6.1 Company Overview
6.7 Medtronic Plc
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental Analysis
6.7.4 Research & Development Analysis
6.8 Johnson & Johnson.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Research & Development Analysis
6.8.4 Segmental Analysis
?
LIST OF TABLES
TABLE 1 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 2 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 3 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 4 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 5 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 6 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 7 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 8 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 9 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 10 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 11 EUROPE CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 12 EUROPE CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 13 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 14 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 15 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 16 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 17 EUROPE DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 18 EUROPE DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 19 EUROPE ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 20 EUROPE ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 21 EUROPE HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 22 EUROPE HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 23 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 24 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 25 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 26 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 27 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 28 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 29 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 30 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 31 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 32 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 33 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 34 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 35 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 36 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 37 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 38 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 39 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 40 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 41 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 42 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 43 RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 44 RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 45 RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 46 RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 47 RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 48 RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 49 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 50 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 51 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 52 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 53 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 54 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 55 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 56 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 57 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 58 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 59 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 60 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 61 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 62 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 63 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 64 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 65 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 66 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 67 KEY INFORMATION - ROCHE DIAGNOSTICS.
TABLE 68 KEY INFORMATION - ABBOTT LABORATORIES.
TABLE 69 KEY INFORMATION - DEXCOM, INC.
TABLE 70 KEY INFORMATION - NOVO NORDISK.
TABLE 71 KEY INFORMATION - YPSOMED AG.
TABLE 72 KEY INFORMATION - GLYSENS INCORPORATED.
TABLE 73 KEY INFORMATION - MEDTRONIC PLC
TABLE 74 KEY INFORMATION - JOHNSON & JOHNSON.
TABLE 1 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 2 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 3 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 4 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 5 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 6 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 7 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 8 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 9 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 10 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 11 EUROPE CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 12 EUROPE CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 13 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 14 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 15 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 16 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 17 EUROPE DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 18 EUROPE DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 19 EUROPE ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 20 EUROPE ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 21 EUROPE HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 22 EUROPE HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 23 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 24 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 25 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 26 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 27 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 28 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 29 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 30 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 31 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 32 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 33 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 34 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 35 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 36 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 37 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 38 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 39 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 40 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 41 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 42 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 43 RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 44 RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 45 RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 46 RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 47 RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 48 RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 49 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 50 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 51 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 52 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 53 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 54 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 55 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 56 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 57 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 58 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 59 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 60 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 61 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 62 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 63 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 64 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 65 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 66 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 67 KEY INFORMATION - ROCHE DIAGNOSTICS.
TABLE 68 KEY INFORMATION - ABBOTT LABORATORIES.
TABLE 69 KEY INFORMATION - DEXCOM, INC.
TABLE 70 KEY INFORMATION - NOVO NORDISK.
TABLE 71 KEY INFORMATION - YPSOMED AG.
TABLE 72 KEY INFORMATION - GLYSENS INCORPORATED.
TABLE 73 KEY INFORMATION - MEDTRONIC PLC
TABLE 74 KEY INFORMATION - JOHNSON & JOHNSON.
